Skip to main content

Published locations for In hemophilia A, emicizumab cuts bleeding; plasma-derived factor VIII less likely to trigger antibodies

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. In hemophilia A, emicizumab cuts bleeding; plasma-derived factor VIII less likely to trigger antibodies

User login

  • Reset your password
  • /content/hemophilia-emicizumab-cuts-bleeding-plasma-derived-factor-viii-less-likely-trigger
  • /hematologynews/article/109136/bleeding-disorders/hemophilia-emicizumab-cuts-bleeding-plasma-derived
  • /internalmedicinenews/article/109136/bleeding-disorders/hemophilia-emicizumab-cuts-bleeding-plasma
  • /pediatricnews/article/109136/bleeding-disorders/hemophilia-emicizumab-cuts-bleeding-plasma-derived
  • /hematology-oncology/article/109136/bleeding-disorders/hemophilia-emicizumab-cuts-bleeding-plasma
  • /pediatrics/article/109136/bleeding-disorders/hemophilia-emicizumab-cuts-bleeding-plasma-derived
  • /internalmedicine/article/109136/bleeding-disorders/hemophilia-emicizumab-cuts-bleeding-plasma